Navigation

    Forum

    • Register
    • Login
    • Search
    • Categories
    • Recent
    • Popular
    • Users
    • Groups

    Contextual Use of a Healthcare Product Name

    FYI post-approval change/preclearance exemption/what requires review/PAAB scope
    2
    2
    92
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • E
      EY last edited by

      Regarding Section 1.5 of the PAAB Code – Materials Not Subject to Preclearance, Section D provides examples (i to v) of contextual use of a healthcare product name. Is this an exhaustive list? If we were to have a different example (not represented on the list) where the healthcare product name was used in a context not linked to therapeutic or promotional messages, could it also be considered not subject to preclearance?

      Jennifer Carroll 1 Reply Last reply Reply Quote 0
      • Jennifer Carroll
        Jennifer Carroll @EY last edited by

        @eyim

        The types of messages listed in section D are exhaustive. However, it is not exhaustive of how the principles might be demonstrated in a specific APS. We offer our opinion services if a company is unsure if an APS meets exemption criteria.

        Please reach our to our admin team at review@paab.ca should you require assistance with this service.

        1 Reply Last reply Reply Quote 0
        • First post
          Last post